Verfügbarkeit: Multi-center phase III clinical trials and NCI cooperative groups :

Multi-center phase III clinical trials and NCI cooperative groups :: workshop summary /

The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovati.

Gespeichert in:

Bibliographische Detailangaben
Körperschaften:	National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.)
Weitere Verfasser:	Patlak, Margie, Nass, Sharyl J., Micheel, Christine
Format:	Elektronisch E-Book
Sprache:	English
Veröffentlicht:	Washington, D.C. : National Academies Press, ©2009.
Schlagworte:	National Cancer Institute (U.S.) Cancer > Treatment > United States. Clinical trials. Clinical Trials, Phase III as Topic Multicenter Studies as Topic Cancer > Traitement > États-Unis. Études cliniques. MEDICAL > Laboratory Medicine. Cancer > Treatment Clinical trials United States Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès.
Online-Zugang:	Volltext
Zusammenfassung:	The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovati.
Beschreibung:	1 online resource (xii, 122 pages)
Bibliographie:	Includes bibliographical references.
ISBN:	9780309128681 0309128684 1282008048 9781282008045

Internformat

MARC


LEADER	00000cam a2200000 a 4500
001	ZDB-4-EBA-ocn310425413
003	OCoLC
005	20241004212047.0
006	m o d
007	cr mnu---uuuuu
008	090224s2009 dcua ob 100 0 eng d
040			\|a MMU \|b eng \|e pn \|c MMU \|d MMU \|d N$T \|d CDX \|d IDEBK \|d OCLCQ \|d E7B \|d OCLCQ \|d WVH \|d OCLCQ \|d XFF \|d OCLCQ \|d YDXCP \|d OCLCF \|d DKDLA \|d OCLCQ \|d NLGGC \|d OCLCQ \|d EBLCP \|d OCLCQ \|d VT2 \|d TOA \|d AGLDB \|d MOR \|d PIFAG \|d ZCU \|d OCLCQ \|d MERUC \|d OCLCQ \|d NJR \|d OCLCO \|d MERER \|d OCLCO \|d U3W \|d OCLCO \|d BUF \|d OCLCO \|d OCLCQ \|d OCLCO \|d CUY \|d OCLCO \|d OCLCQ \|d STF \|d WRM \|d VNS \|d OCLCO \|d OCLCQ \|d VTS \|d OCLCO \|d COCUF \|d NRAMU \|d EZ9 \|d OCLCQ \|d ICG \|d OCLCO \|d OCLCQ \|d WYU \|d OCLCO \|d OCLCA \|d LVT \|d OCLCA \|d U3G \|d OCLCO \|d DKC \|d OCLCQ \|d OCLCO \|d M8D \|d UKAHL \|d OCLCQ \|d OCLCA \|d UKCRE \|d KIJ \|d OCLCQ \|d TUHNV \|d OCLCO \|d SFB \|d OCL \|d OCLCQ \|d OCLCO \|d OCLCL
019			\|a 318632938 \|a 367589822 \|a 764510222 \|a 815764114 \|a 923279910 \|a 961631136 \|a 962693547 \|a 988478267 \|a 992070783 \|a 1028757774 \|a 1037916556 \|a 1038580988 \|a 1045473363 \|a 1047526131 \|a 1055338849 \|a 1062877440 \|a 1081185896 \|a 1153526253 \|a 1156353483 \|a 1204379244 \|a 1204385000 \|a 1228615038 \|a 1243581436
020			\|a 9780309128681 \|q (electronic bk.)
020			\|a 0309128684 \|q (electronic bk.)
020			\|a 1282008048
020			\|a 9781282008045
020			\|z 9780309128674 \|q (pbk.)
020			\|z 0309128676 \|q (pbk.)
035			\|a (OCoLC)310425413 \|z (OCoLC)318632938 \|z (OCoLC)367589822 \|z (OCoLC)764510222 \|z (OCoLC)815764114 \|z (OCoLC)923279910 \|z (OCoLC)961631136 \|z (OCoLC)962693547 \|z (OCoLC)988478267 \|z (OCoLC)992070783 \|z (OCoLC)1028757774 \|z (OCoLC)1037916556 \|z (OCoLC)1038580988 \|z (OCoLC)1045473363 \|z (OCoLC)1047526131 \|z (OCoLC)1055338849 \|z (OCoLC)1062877440 \|z (OCoLC)1081185896 \|z (OCoLC)1153526253 \|z (OCoLC)1156353483 \|z (OCoLC)1204379244 \|z (OCoLC)1204385000 \|z (OCoLC)1228615038 \|z (OCoLC)1243581436
043			\|a n-us---
050		4	\|a R853.C55 \|b M85 2009eb
060		4	\|a 2009 F-375
060		4	\|a QV 771 \|b M9605 2009
072		7	\|a MED \|x 047000 \|2 bisacsh
072		7	\|a M \|2 bicssc
082	7		\|a 610.724 \|2 22
049			\|a MAIN
245	0	0	\|a Multi-center phase III clinical trials and NCI cooperative groups : \|b workshop summary / \|c Margie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies.
260			\|a Washington, D.C. : \|b National Academies Press, \|c ©2009.
300			\|a 1 online resource (xii, 122 pages)
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
504			\|a Includes bibliographical references.
505	0		\|a Introduction -- Organization of the NCI clinical trials system -- Lessons from non-cooperative group multi-center clinical trials -- Barriers to patient recruitment and physician participation -- Data collection standards and monitoring -- Costs of cooperative group clinical trials -- Summary and wrap-up.
588	0		\|a Print version record.
520			\|a The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovati.
610	2	2	\|a National Cancer Institute (U.S.)
650		0	\|a Cancer \|x Treatment \|z United States.
650		0	\|a Clinical trials. \|0 http://id.loc.gov/authorities/subjects/sh85027069
650	1	2	\|a Clinical Trials, Phase III as Topic \|0 https://id.nlm.nih.gov/mesh/D017326
650	1	2	\|a Multicenter Studies as Topic \|0 https://id.nlm.nih.gov/mesh/D015337
651		2	\|a United States \|0 https://id.nlm.nih.gov/mesh/D014481
650		6	\|a Cancer \|x Traitement \|z États-Unis.
650		6	\|a Études cliniques.
650		7	\|a MEDICAL \|x Laboratory Medicine. \|2 bisacsh
650		7	\|a Cancer \|x Treatment \|2 fast
650		7	\|a Clinical trials \|2 fast
651		7	\|a United States \|2 fast \|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
655		2	\|a Congress
655		7	\|a proceedings (reports) \|2 aat
655		7	\|a Conference papers and proceedings \|2 fast
655		7	\|a Conference papers and proceedings. \|2 lcgft \|0 http://id.loc.gov/authorities/genreForms/gf2014026068
655		7	\|a Actes de congrès. \|2 rvmgf
700	1		\|a Patlak, Margie. \|0 http://id.loc.gov/authorities/names/n2002014880
700	1		\|a Nass, Sharyl J. \|0 http://id.loc.gov/authorities/names/n2001127655
700	1		\|a Micheel, Christine. \|0 http://id.loc.gov/authorities/names/no2009004337
710	2		\|a National Cancer Policy Forum (U.S.) \|0 http://id.loc.gov/authorities/names/n2006183479
710	2		\|a Institute of Medicine (U.S.) \|0 http://id.loc.gov/authorities/names/n79129181
758			\|i has work: \|a Multi-center phase III clinical trials and NCI cooperative groups (Text) \|1 https://id.oclc.org/worldcat/entity/E39PCGBv4RHbdgb7pvWqjkKKMK \|4 https://id.oclc.org/worldcat/ontology/hasWork
776	0	8	\|i Print version: \|t Multi-center phase III clinical trials and NCI cooperative groups: workshop summary. \|d Washington, D.C. : National Academies Press, ©2009 \|z 9780309128674 \|w (OCoLC)310392638
856	4	0	\|l FWS01 \|p ZDB-4-EBA \|q FWS_PDA_EBA \|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=268391 \|3 Volltext
938			\|a Askews and Holts Library Services \|b ASKH \|n AH36616593
938			\|a Askews and Holts Library Services \|b ASKH \|n AH36558415
938			\|a Coutts Information Services \|b COUT \|n 9832980
938			\|a ProQuest Ebook Central \|b EBLB \|n EBL3378456
938			\|a ebrary \|b EBRY \|n ebr10280005
938			\|a EBSCOhost \|b EBSC \|n 268391
938			\|a ProQuest MyiLibrary Digital eBook Collection \|b IDEB \|n 200804
938			\|a YBP Library Services \|b YANK \|n 3045644
994			\|a 92 \|b GEBAY
912			\|a ZDB-4-EBA
049			\|a DE-863

Datensatz im Suchindex

DE-BY-FWS_katkey	ZDB-4-EBA-ocn310425413
_version_	1816881687215210497
adam_text
any_adam_object
author2	Patlak, Margie Nass, Sharyl J. Micheel, Christine
author2_role
author2_variant	m p mp s j n sj sjn c m cm
author_GND	http://id.loc.gov/authorities/names/n2002014880 http://id.loc.gov/authorities/names/n2001127655 http://id.loc.gov/authorities/names/no2009004337
author_corporate	National Cancer Policy Forum (U.S.) Institute of Medicine (U.S.)
author_corporate_role
author_facet	Patlak, Margie Nass, Sharyl J. Micheel, Christine National Cancer Policy Forum (U.S.) Institute of Medicine (U.S.)
author_sort	Patlak, Margie
building	Verbundindex
bvnumber	localFWS
callnumber-first	R - Medicine
callnumber-label	R853
callnumber-raw	R853.C55 M85 2009eb
callnumber-search	R853.C55 M85 2009eb
callnumber-sort	R 3853 C55 M85 42009EB
callnumber-subject	R - General Medicine
collection	ZDB-4-EBA
contents	Introduction -- Organization of the NCI clinical trials system -- Lessons from non-cooperative group multi-center clinical trials -- Barriers to patient recruitment and physician participation -- Data collection standards and monitoring -- Costs of cooperative group clinical trials -- Summary and wrap-up.
ctrlnum	(OCoLC)310425413
dewey-full	610.724
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	610 - Medicine and health
dewey-raw	610.724
dewey-search	610.724
dewey-sort	3610.724
dewey-tens	610 - Medicine and health
discipline	Medizin
format	Electronic eBook
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05583cam a2200829 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn310425413</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr mnu---uuuuu</controlfield><controlfield tag="008">090224s2009 dcua ob 100 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MMU</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">MMU</subfield><subfield code="d">MMU</subfield><subfield code="d">N$T</subfield><subfield code="d">CDX</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WVH</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">XFF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCF</subfield><subfield code="d">DKDLA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VT2</subfield><subfield code="d">TOA</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NJR</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MERER</subfield><subfield code="d">OCLCO</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCO</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">CUY</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">COCUF</subfield><subfield code="d">NRAMU</subfield><subfield code="d">EZ9</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">LVT</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3G</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">M8D</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKCRE</subfield><subfield code="d">KIJ</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TUHNV</subfield><subfield code="d">OCLCO</subfield><subfield code="d">SFB</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">318632938</subfield><subfield code="a">367589822</subfield><subfield code="a">764510222</subfield><subfield code="a">815764114</subfield><subfield code="a">923279910</subfield><subfield code="a">961631136</subfield><subfield code="a">962693547</subfield><subfield code="a">988478267</subfield><subfield code="a">992070783</subfield><subfield code="a">1028757774</subfield><subfield code="a">1037916556</subfield><subfield code="a">1038580988</subfield><subfield code="a">1045473363</subfield><subfield code="a">1047526131</subfield><subfield code="a">1055338849</subfield><subfield code="a">1062877440</subfield><subfield code="a">1081185896</subfield><subfield code="a">1153526253</subfield><subfield code="a">1156353483</subfield><subfield code="a">1204379244</subfield><subfield code="a">1204385000</subfield><subfield code="a">1228615038</subfield><subfield code="a">1243581436</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309128681</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309128684</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282008048</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282008045</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309128674</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309128676</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)310425413</subfield><subfield code="z">(OCoLC)318632938</subfield><subfield code="z">(OCoLC)367589822</subfield><subfield code="z">(OCoLC)764510222</subfield><subfield code="z">(OCoLC)815764114</subfield><subfield code="z">(OCoLC)923279910</subfield><subfield code="z">(OCoLC)961631136</subfield><subfield code="z">(OCoLC)962693547</subfield><subfield code="z">(OCoLC)988478267</subfield><subfield code="z">(OCoLC)992070783</subfield><subfield code="z">(OCoLC)1028757774</subfield><subfield code="z">(OCoLC)1037916556</subfield><subfield code="z">(OCoLC)1038580988</subfield><subfield code="z">(OCoLC)1045473363</subfield><subfield code="z">(OCoLC)1047526131</subfield><subfield code="z">(OCoLC)1055338849</subfield><subfield code="z">(OCoLC)1062877440</subfield><subfield code="z">(OCoLC)1081185896</subfield><subfield code="z">(OCoLC)1153526253</subfield><subfield code="z">(OCoLC)1156353483</subfield><subfield code="z">(OCoLC)1204379244</subfield><subfield code="z">(OCoLC)1204385000</subfield><subfield code="z">(OCoLC)1228615038</subfield><subfield code="z">(OCoLC)1243581436</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R853.C55</subfield><subfield code="b">M85 2009eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2009 F-375</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 771</subfield><subfield code="b">M9605 2009</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">047000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">M</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">610.724</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Multi-center phase III clinical trials and NCI cooperative groups :</subfield><subfield code="b">workshop summary /</subfield><subfield code="c">Margie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">©2009.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 122 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Introduction -- Organization of the NCI clinical trials system -- Lessons from non-cooperative group multi-center clinical trials -- Barriers to patient recruitment and physician participation -- Data collection standards and monitoring -- Costs of cooperative group clinical trials -- Summary and wrap-up.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovati.</subfield></datafield><datafield tag="610" ind1="2" ind2="2"><subfield code="a">National Cancer Institute (U.S.)</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical trials.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85027069</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Clinical Trials, Phase III as Topic</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D017326</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Multicenter Studies as Topic</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D015337</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014481</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Traitement</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Études cliniques.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Laboratory Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Congress</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">proceedings (reports)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings.</subfield><subfield code="2">lcgft</subfield><subfield code="0">http://id.loc.gov/authorities/genreForms/gf2014026068</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Actes de congrès.</subfield><subfield code="2">rvmgf</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patlak, Margie.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2002014880</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nass, Sharyl J.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2001127655</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Micheel, Christine.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2009004337</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2006183479</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="0">http://id.loc.gov/authorities/names/n79129181</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Multi-center phase III clinical trials and NCI cooperative groups (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGBv4RHbdgb7pvWqjkKKMK</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Multi-center phase III clinical trials and NCI cooperative groups: workshop summary.</subfield><subfield code="d">Washington, D.C. : National Academies Press, ©2009</subfield><subfield code="z">9780309128674</subfield><subfield code="w">(OCoLC)310392638</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=268391</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36616593</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36558415</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">9832980</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3378456</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10280005</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">268391</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">200804</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3045644</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection>
genre	Congress proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf
genre_facet	Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès.
geographic	United States https://id.nlm.nih.gov/mesh/D014481 United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
geographic_facet	United States
id	ZDB-4-EBA-ocn310425413
illustrated	Illustrated
indexdate	2024-11-27T13:16:40Z
institution	BVB
institution_GND	http://id.loc.gov/authorities/names/n2006183479 http://id.loc.gov/authorities/names/n79129181
isbn	9780309128681 0309128684 1282008048 9781282008045
language	English
oclc_num	310425413
open_access_boolean
owner	MAIN DE-863 DE-BY-FWS
owner_facet	MAIN DE-863 DE-BY-FWS
physical	1 online resource (xii, 122 pages)
psigel	ZDB-4-EBA
publishDate	2009
publishDateSearch	2009
publishDateSort	2009
publisher	National Academies Press,
record_format	marc
spelling	Multi-center phase III clinical trials and NCI cooperative groups : workshop summary / Margie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies. Washington, D.C. : National Academies Press, ©2009. 1 online resource (xii, 122 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references. Introduction -- Organization of the NCI clinical trials system -- Lessons from non-cooperative group multi-center clinical trials -- Barriers to patient recruitment and physician participation -- Data collection standards and monitoring -- Costs of cooperative group clinical trials -- Summary and wrap-up. Print version record. The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovati. National Cancer Institute (U.S.) Cancer Treatment United States. Clinical trials. http://id.loc.gov/authorities/subjects/sh85027069 Clinical Trials, Phase III as Topic https://id.nlm.nih.gov/mesh/D017326 Multicenter Studies as Topic https://id.nlm.nih.gov/mesh/D015337 United States https://id.nlm.nih.gov/mesh/D014481 Cancer Traitement États-Unis. Études cliniques. MEDICAL Laboratory Medicine. bisacsh Cancer Treatment fast Clinical trials fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Congress proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf Patlak, Margie. http://id.loc.gov/authorities/names/n2002014880 Nass, Sharyl J. http://id.loc.gov/authorities/names/n2001127655 Micheel, Christine. http://id.loc.gov/authorities/names/no2009004337 National Cancer Policy Forum (U.S.) http://id.loc.gov/authorities/names/n2006183479 Institute of Medicine (U.S.) http://id.loc.gov/authorities/names/n79129181 has work: Multi-center phase III clinical trials and NCI cooperative groups (Text) https://id.oclc.org/worldcat/entity/E39PCGBv4RHbdgb7pvWqjkKKMK https://id.oclc.org/worldcat/ontology/hasWork Print version: Multi-center phase III clinical trials and NCI cooperative groups: workshop summary. Washington, D.C. : National Academies Press, ©2009 9780309128674 (OCoLC)310392638 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=268391 Volltext
spellingShingle	Multi-center phase III clinical trials and NCI cooperative groups : workshop summary / Introduction -- Organization of the NCI clinical trials system -- Lessons from non-cooperative group multi-center clinical trials -- Barriers to patient recruitment and physician participation -- Data collection standards and monitoring -- Costs of cooperative group clinical trials -- Summary and wrap-up. National Cancer Institute (U.S.) Cancer Treatment United States. Clinical trials. http://id.loc.gov/authorities/subjects/sh85027069 Clinical Trials, Phase III as Topic https://id.nlm.nih.gov/mesh/D017326 Multicenter Studies as Topic https://id.nlm.nih.gov/mesh/D015337 Cancer Traitement États-Unis. Études cliniques. MEDICAL Laboratory Medicine. bisacsh Cancer Treatment fast Clinical trials fast
subject_GND	http://id.loc.gov/authorities/subjects/sh85027069 https://id.nlm.nih.gov/mesh/D017326 https://id.nlm.nih.gov/mesh/D015337 https://id.nlm.nih.gov/mesh/D014481 http://id.loc.gov/authorities/genreForms/gf2014026068
title	Multi-center phase III clinical trials and NCI cooperative groups : workshop summary /
title_auth	Multi-center phase III clinical trials and NCI cooperative groups : workshop summary /
title_exact_search	Multi-center phase III clinical trials and NCI cooperative groups : workshop summary /
title_full	Multi-center phase III clinical trials and NCI cooperative groups : workshop summary / Margie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies.
title_fullStr	Multi-center phase III clinical trials and NCI cooperative groups : workshop summary / Margie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies.
title_full_unstemmed	Multi-center phase III clinical trials and NCI cooperative groups : workshop summary / Margie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies.
title_short	Multi-center phase III clinical trials and NCI cooperative groups :
title_sort	multi center phase iii clinical trials and nci cooperative groups workshop summary
title_sub	workshop summary /
topic	National Cancer Institute (U.S.) Cancer Treatment United States. Clinical trials. http://id.loc.gov/authorities/subjects/sh85027069 Clinical Trials, Phase III as Topic https://id.nlm.nih.gov/mesh/D017326 Multicenter Studies as Topic https://id.nlm.nih.gov/mesh/D015337 Cancer Traitement États-Unis. Études cliniques. MEDICAL Laboratory Medicine. bisacsh Cancer Treatment fast Clinical trials fast
topic_facet	National Cancer Institute (U.S.) Cancer Treatment United States. Clinical trials. Clinical Trials, Phase III as Topic Multicenter Studies as Topic United States Cancer Traitement États-Unis. Études cliniques. MEDICAL Laboratory Medicine. Cancer Treatment Clinical trials Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès.
url	https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=268391
work_keys_str_mv	AT patlakmargie multicenterphaseiiiclinicaltrialsandncicooperativegroupsworkshopsummary AT nasssharylj multicenterphaseiiiclinicaltrialsandncicooperativegroupsworkshopsummary AT micheelchristine multicenterphaseiiiclinicaltrialsandncicooperativegroupsworkshopsummary AT nationalcancerpolicyforumus multicenterphaseiiiclinicaltrialsandncicooperativegroupsworkshopsummary AT instituteofmedicineus multicenterphaseiiiclinicaltrialsandncicooperativegroupsworkshopsummary

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Volltext öffnen

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge